To turn clinical and real-world data into evidence that regulators, payers and clinicians can rely on.
- Regulators
- Payers
- Clinicians
Biometrics, clinical data sciences, real-world evidence and HEOR, brought together by one partner.

Stage Analytics helps pharmaceutical, biotechnology, medical device, and healthcare organizations transform clinical and real-world data into regulatory-grade evidence through biostatistics, statistical programming, HEOR, market access research, observational studies, and advanced analytics.
We bring biometrics, clinical data sciences, real-world evidence, HEOR and market access, evidence synthesis, scientific communications and clinical operations together, so the evidence a product needs is designed, generated and communicated as one connected body of work.

At a glance
What we do for clients today, and where that work is heading.
To turn clinical and real-world data into evidence that regulators, payers and clinicians can rely on.
One partner for evidence across the product lifecycle, from the first protocol to market access.
Each practice area connects to the next, from clinical trial design and data capture to regulatory submissions, real-world evidence and market access.
Four habits that run through every study, dataset and deliverable.
Statistical design, endpoints and sample size are settled early, so every later dataset and output has a clear basis.
CDISC SDTM and ADaM, Define.xml, cSDRG and ADRG, with submission compliance considered from the start.
QC programming, validation testing, reconciliation and edit checks are part of the workflow, not an afterthought.
Methods and data carry from clinical trials into real-world evidence, HEOR and market access.
Short answers about who we are and how we work.
A clinical data science company that brings biometrics, clinical data sciences, real-world evidence and HEOR together in one partner.
Pharmaceutical, biotechnology, medical device and healthcare organizations.
Biometrics, clinical data sciences, real-world evidence, HEOR and market access, evidence synthesis, scientific communications and clinical operations.
Statistical design comes first, deliverables follow CDISC standards, and QC programming and validation are part of the workflow.
Yes. We cover clinical trials, biometrics, data management, regulatory submissions, real-world evidence, HEOR and market access.
Have a different question? Contact our team
Tell us where you are in the product lifecycle and we will outline how our biometrics, data and evidence teams can support it.
Start with what you need